Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center, Prospective, Randomized, Controlled Trial of Endobronchial Valve Therapy vs. Standard of Care in Heterogeneous Emphysema

NCT02022683 is registered in ClinicalTrials.gov with Pulmonx Corporation as lead sponsor.

NCT NCT02022683
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02022683 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center, Prospective, Randomized, Controlled Trial of Endobronchial Valve Therapy vs. Standard of Care in Heterogeneous Emphysema
Lead sponsor
Pulmonx Corporation
Phase
Not applicable
Overall status
Completed
Start date
January 28, 2014
Completion date
September 27, 2018
Enrollment
97 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

copd, heterogeneous emphysema